...
首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Synthesis of novel benzenesulfamide derivatives with inhibitory activity against human cytosolic carbonic anhydrase I and II and Vibrio cholerae α- and β-class enzymes
【24h】

Synthesis of novel benzenesulfamide derivatives with inhibitory activity against human cytosolic carbonic anhydrase I and II and Vibrio cholerae α- and β-class enzymes

机译:具有抑制人胞质碳酸酐酶I和II和霍乱弧菌α-和β-类酶活性的新型苯磺酰胺衍生物的合成

获取原文
           

摘要

Abstract The synthesis of a new series of sulfamides incorporating ortho-, meta, and para-benzenesulfamide moieties is reported, which were investigated for the inhibition of two human (h) isoforms of the zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1), hCA I and II, and two Vibrio cholerae enzymes, belonging to the α- and β-CA classes (VchCAα, VchCAβ). The compounds were prepared by using the “tail approach”, aiming to overcome the scarcity of selective inhibition profiles associated to CA inhibitors belonging to the zinc binders. The built structure–activity relationship showed that the incorporation of benzhydryl piperazine tails on a phenyl sulfamide scaffold determines rather good efficacies against hCA I and VchCAα, with several compounds showing KIs?
机译:摘要据报道,合成了一系列新的结合了邻,间和对苯磺酰胺基团的磺酰胺,并对其抑制锌酶碳酸酐酶的两种人(h)同工型进行了研究(CA,EC 4.2.1.1) ,hCA I和II,以及两种霍乱弧菌酶,分别属于α-和β-CA类(VchCAα,VchCAβ)。化合物是通过“尾巴法”制备的,目的是克服与属于锌结合剂的CA抑制剂相关的选择性抑制谱的不足。建立的结构-活性关系表明,苯硫基哌嗪尾部在苯基磺酰胺支架上的结合确定了对hCA I和VchCAα的相当好的功效,其中几种化合物显示出K I s≤100≤nM。针对hCA II和VchCAβ的活性较低,可能是由于掺入的尾巴非常笨重。获得的证据使我们能够继续研究不同的尾巴/锌结合基团,以提高这种抑制剂对病原体细菌CA的有效性/选择性,从而提供潜在的新型抗感染剂。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号